{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:27:57Z","timestamp":1786728477532,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:p>Polymyalgia rheumatica (PMR) is an inflammatory rheumatic condition characterized by pain and stiffness around the shoulders and hip girdles, an elevated erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP) and a dramatic response to corticosteroids. It is usually seen in adults aged over 50 years; about 30% also have giant cell arteritis. Its etiology is unknown. A 72-year-old male received water vapor therapy, a novel, minimally invasive therapy for benign prostate hypertrophy (BPH). On postoperative day 1, he developed severe shoulder pain and weakness, with difficulty with lifting his arms above his head, and hip pain and weakness, with difficulty getting out of a bed or chair. Laboratory results showed elevated ESR and CRP, but a normal creatine kinase level. The patient received low-dose prednisone and had prompt symptom relief. This case illustrates that a diagnosis of PMR after water vapor therapy can be easily overlooked.<\/jats:p>","DOI":"10.4103\/jfmpc.jfmpc_676_23","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T05:03:02Z","timestamp":1700456582000},"page":"2976-2978","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Water vapor therapy and polymyalgia rheumatica: Coincidental?"],"prefix":"10.4103","volume":"12","author":[{"given":"Joshua","family":"Lee","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Keck Medicine of USC, Los Angeles, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Keck Medicine of USC, Los Angeles, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy U.","family":"Nguyen-Oghalai","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Keck Medicine of USC, Los Angeles, California, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,11,21]]},"reference":[{"key":"R1-20260512","article-title":"Polymyalgia Rheumatica","author":"Acharya","year":"2023"},{"key":"R2-20260512","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s40266-019-00705-5","article-title":"Pathogenesis, diagnosis and management of polymyalgia rheumatica","volume":"36","author":"Camellino","year":"2019","journal-title":"Drugs Aging"},{"key":"R3-20260512","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.juro.2015.10.181","article-title":"Minimally invasive prostate convective water vapor energy ablation: A multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"195","author":"McVary","year":"2016","journal-title":"J Urol"},{"key":"R4-20260512","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/JU.0000000000001778","article-title":"Final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"206","author":"McVary","year":"2021","journal-title":"J Urol"},{"key":"R5-20260512","doi-asserted-by":"crossref","first-page":"452","DOI":"10.5152\/tud.2021.21128","article-title":"Role of Rezum in the treatment of benign prostate hyperplasia: A review of the literature","volume":"47","author":"Cocci","year":"2021","journal-title":"Turk J Urol"},{"key":"R6-20260512","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/luts.12435","article-title":"Emerging outcomes of water vapor thermal therapy (Rezum) in a broad range of patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia: A systematic review","volume":"14","author":"Babar","year":"2022","journal-title":"Low Urin Tract Symptoms"},{"key":"R7-20260512","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/bju.15154","article-title":"The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia","volume":"126","author":"Madersbacher","year":"2020","journal-title":"BJU Int"},{"key":"R8-20260512","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s11255-021-02878-8","article-title":"Rezum: A novel minimally invasive treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. A review article","volume":"53","author":"Higazy","year":"2021","journal-title":"Int Urol Nephrol"},{"key":"R9-20260512","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/joim.13525","article-title":"An update on polymyalgia rheumatica","volume":"292","author":"Lundberg","year":"2022","journal-title":"J Intern Med"},{"key":"R10-20260512","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4081\/reumatismo.2018.1040","article-title":"Imaging in polymyalgia rheumatica","volume":"70","author":"Possemato","year":"2018","journal-title":"Reumatismo"},{"key":"R11-20260512","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.39333","article-title":"2015 recommendations for the management of polymyalgia rheumatica: A European league against rheumatism\/American college of rheumatology collaborative initiative","volume":"67","author":"Dejaco","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R12-20260512","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrrheum.2012.97","article-title":"Clinical features of polymyalgia rheumatica and giant cell arteritis","volume":"8","author":"Salvarani","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"R13-20260512","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10067-021-05819-z","article-title":"Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: A systematic literature review and meta-analysis","volume":"41","author":"Floris","year":"2022","journal-title":"Clin Rheumatol"},{"key":"R14-20260512","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/joim.13525","article-title":"An update on polymyalgia rheumatica","volume":"292","author":"Lundberg","year":"2022","journal-title":"J Intern Med"},{"key":"R15-20260512","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1001\/archinternmed.2009.352","article-title":"Treatment of polymyalgia rheumatica: A systematic review","volume":"169","author":"Hern\u00e1ndez-Rodr\u00edguez","year":"2009","journal-title":"Arch Intern Med"},{"key":"R16-20260512","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/JXX.0000000000000756","article-title":"Alternatives to glucocorticoid monotherapy in the treatment of polymyalgia rheumatica","volume":"34","author":"Walz","year":"2022","journal-title":"J Am Assoc Nurse Pract"},{"key":"R17-20260512","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/jama.2022.15459","article-title":"Effect of tocilizumab on disease activity in patients with active polymyalgia rheumatica receiving glucocorticoid therapy: A randomized clinical trial","volume":"328","author":"Devauchelle-Pensec","year":"2022","journal-title":"JAMA"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_676_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:27:29Z","timestamp":1786724849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_676_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_676_23","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"2023-04-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}